Gut microbiota–derived trimethylamine N-oxide (TMAO) and its association with neuroinflammation in migraine
The Indian Journal of Medical Research · 01.08.2026 · 164 · 179-184
DOI: 10.25259/ijmr_3392_2025 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Indian Journal of Medical Research, online erschienen am 01.08.2026. Verfasst von Yasemin Atıcı und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biochemistry, Lokman Hekim University, Ankara, Turkey. Hauptthemen laut MEDLINE: Methylamines, Migraine Disorders, Gastrointestinal Microbiome, Neuroinflammatory Diseases. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background and objectives Migraine is a common primary headache disorder associated with neuroinflammation, with evidence implicating gut microbiota and metabolites in neurological mechanisms pathways. Since trimethylamine-N-oxide (TMAO), derived from dietary precursors by gut microbial metabolism, is associated with cardiovascular and neurodegenerative conditions, and its role in migraines is unclear, we aimed to evaluate whether serum TMAO level and related metabolites in migraine patients can be biomarkers.
Methods
A total of 106 participants were enrolled, consisting of healthy controls (n=46; mean age ± SD=39±8 yr old) and migraine patients (n=60). The migraine cohort was divided into migraine with aura (n=18; mean age±SD=33±11 yr old) and migraine without aura (n=42; mean age±SD=37±10 yr old), according to the International Classification of Headache Disorders, 3rd edition (ICHD-3). Blood samples were centrifuged, stored at –80°C, and analysed for TMAO, carnitine, betaine, and choline levels using liquid chromatography–mass spectrometry (LC-MS/MS).
Results
There were no significant differences between the groups for age, smoking, or body mass index (BMI). Serum TMAO levels were significantly higher in patients with migraine with aura [2.75 (1.98–3.91) ng/mL] and migraine without aura [2.85 (2.08–5.53) ng/mL] compared to controls [1.40 (1.00–3.01) ng/mL] ( P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Biochemistry, Lokman Hekim University, Ankara, Turkey.
- Department of Neurology, Lokman Hekim University, Ankara, Turkey.
- Department of Faculty of Medicine, Lokman Hekim University, Ankara, Turkey.
- Department of Medical Biology and Genetics, Faculty of Medicine, Ankara Medipol University, Ankara, Turkey.
- Department of Medical Biochemistry, Faculty of Medicine, Acibadem Mehmet Ali Aydinlar University, Istanbul, Turkey.
Zitieren
APA
Atıcı, Y., Eruyar, E., Ökten, Z., Serdar, C. C., Serdar, M. A., & Yücel, D. (2026). Gut microbiota–derived trimethylamine N-oxide (TMAO) and its association with neuroinflammation in migraine. The Indian Journal of Medical Research, 164, 179-184. https://doi.org/10.25259/ijmr_3392_2025
Vancouver
Atıcı Y, Eruyar E, Ökten Z, Serdar CC, Serdar MA, Yücel D. Gut microbiota–derived trimethylamine N-oxide (TMAO) and its association with neuroinflammation in migraine. The Indian Journal of Medical Research. 2026;164:179-184. doi:10.25259/ijmr_3392_2025
BibTeX
@article{Atc2026,
author = {Atıcı, Yasemin and Eruyar, Esra and Ökten, Zeynep and Serdar, Ceyhan Ceran and Serdar, Muhittin A and Yücel, Doğan},
title = {Gut microbiota–derived trimethylamine N-oxide (TMAO) and its association with neuroinflammation in migraine},
journal = {The Indian Journal of Medical Research},
year = {2026},
volume = {164},
pages = {179--184},
doi = {10.25259/ijmr_3392_2025}
}
EUVIMED